Reply
Nicolas Goldaracena, Juan Echeverri, Markus Selzner – 27 December 2016
Fecal microbiota transplantation induces hepatitis B virus e‐antigen (HBeAg) clearance in patients with positive HBeAg after long‐term antiviral therapy
Yan‐Dan Ren, Zhen‐Shi Ye, Liu‐Zhu Yang, Li‐Xin Jin, Wen‐Jun Wei, Yong‐Yue Deng, Xiao‐Xiao Chen, Chuan‐Xing Xiao, Xiao‐Fang Yu, Hong‐Zhi Xu, Li‐Zhu Xu, Yun‐Na Tang, Fei Zhou, Xue‐Lian Wang, Mei‐Ya Chen, Li‐Gang Chen, Mei‐Zhu Hong, Jian‐Lin Ren, Jin‐Shui Pan – 27 December 2016
Liver transplantation for hepatocellular carcinoma through the lens of transplant benefit
Umberto Cillo, Alessandro Vitale, Marina Polacco, Elisa Fasolo – 23 December 2016
Aspirin for cholangiocarcinoma prevention: New targets to shift the dogma from ascertained risk to possible prevention
Giovanni Brandi, Stefania De Lorenzo, Andrea Palloni, Guido Biasco, Francesco Tovoli – 23 December 2016
Reply:
Gordon D. McLaren, James C. Barton, Grant A. Ramm, Mary J. Emond, V. Nathan Subramaniam, Pradyumna D. Phatak, Paul C. Adams, Lawrie W. Powell, Lyle C. Gurrin, Gregory J. Anderson, Christine E. McLaren – 23 December 2016
Effect of metabolic syndrome on cardiovascular, hepatic events, and death in chronic hepatitis B patients: Methodological issues
Erfan Ayubi, Saeid Safiri, Mohadeseh Sani, Amin Doosti‐Irani, Ali Sanjari Moghaddam – 23 December 2016
Reply
Jenny Yeuk‐Ki Cheng, Yee‐Kit Tse, Grace Lai‐Hung Wong – 23 December 2016
Sofosbuvir/ledipasvir and ribavirin tolerability and efficacy in pediatric liver transplant recipients
Koen Huysentruyt, Xavier Stephenne, Sharat Varma, Isabelle Scheers, Gisèle Leclercq, Françoise Smets, Etienne M. Sokal – 22 December 2016
Impact of emergency adult living donor liver transplantation on the survival of patients with antituberculosis therapy‐induced acute liver failure
Jin‐Young Huh, Danbi Lee, Jihyun Ahn, Ju Hyun Shim, Young‐Suk Lim, Gil‐Chun Park, Gi‐Won Song, Ki‐Hun Kim, Dong‐Hwan Jung, Deok‐Bog Moon, Shin Hwang, Sung Gyu Lee, Sei Won Lee, Jin‐Woo Song, Yeon‐Mok Oh, Tae Sun Shim, Kyung‐Wook Jo – 22 December 2016
Neutrophil‐to‐lymphocyte ratio correlates with proinflammatory neutrophils and predicts death in low model for end‐stage liver disease patients with cirrhosis
Avash Kalra, Joel P. Wedd, Kiran M. Bambha, Jane Gralla, Lucy Golden‐Mason, Christine Collins, Hugo R. Rosen, Scott W. Biggins – 22 December 2016 – The Model for End‐Stage Liver Disease (MELD) score has reduced accuracy for liver transplantation (LT) wait‐list mortality when MELD ≤ 20. Neutrophil‐to‐lymphocyte ratio (NLR) is a biomarker associated with systemic inflammation and may predict cirrhotic decompensation and death. We aimed to evaluate the prognostic utility of high NLR (≥4) for liver‐related death among low MELD patients listed for LT, controlling for stage of cirrhosis.